関連レポート

出版元：Transparency Market Research  出版元について

発行年：2024年7月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 145ページになります。

商品コード：TMR319

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

ポリクローナル抗体の世界市場規模は2023年で11億ドル、2034年に20億ドル、市場の平均年成長率は5.5%にて増加する見込みです。

当レポートでは、ポリクローナル抗体の市場予測-2034年、各種セグメント別市場分析(タイプ別、用途別、国地域別、等)、パイプライン分析、主要製品/ブランド分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■ポリクローナル抗体の世界市場予測2020-2034年
・市場規模(US$)

■タイプ別、市場-2034年
・一次抗体
・二次抗体
※(市場規模US$)　

■用途別、市場-2034年
・診断/治療
・研究用途
・創薬、医薬品開発
※(市場規模US$)　

■エンドユーザー別、市場-2034年
・製薬、バイオテクノロジー企業
・学術、研究機関
・医薬品開発業務受託機関（CRO）
・その他
※(市場規模US$)

■主要国地域別市場-2034年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
市場ダイナミクス
パイプライン分析
主要製品/ブランド分析
主要な合併、買収

■ポリクローナル抗体の主要企業プロフィール動向
Good Biotech Corp
Rockland Immunochemicals, Inc.
EpigenTek Group Inc.
Innovagen AB
GeneTex, Inc.
Abcam Limited
GenScript Biotech
The Merck Group
IGY Life Sciences
Thermo Fisher Scientific Inc.
Takara Bio USA, Inc.
GenWay Biotech, Inc.
（全145頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Polyclonal Antibody Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Polyclonal Antibody Market Analysis and Forecast, 2020-2034

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Polyclonal Antibody Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2034
6.3.1. Primary Antibodies
6.3.2. Secondary Antibodies
6.4. Market Attractiveness Analysis, by Type

7. Global Polyclonal Antibody Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Diagnostic & Therapeutic Application
7.3.2. Research Application
7.3.3. Drug Discovery and Development
7.4. Market Attractiveness Analysis, by Application

8. Global Polyclonal Antibody Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Pharmaceutical and Biotechnology Companies
8.3.2. Academic and Research Institutes
8.3.3. Contract Research Organizations (CROs)
8.4. Market Attractiveness Analysis, by End-user

9. Global Polyclonal Antibody Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Polyclonal Antibody Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type, 2020-2034
10.3.1. Primary Antibodies
10.3.2. Secondary Antibodies
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Diagnostic & Therapeutic Application
10.4.2. Research Application
10.4.3. Drug Discovery and Development
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Pharmaceutical and Biotechnology Companies
10.5.2. Academic and Research Institutes
10.5.3. Contract Research Organizations (CROs)
10.5.4. Others
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country

11. Europe Polyclonal Antibody Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type, 2020-2034
11.3.1. Primary Antibodies
11.3.2. Secondary Antibodies
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Diagnostic & Therapeutic Application
11.4.2. Research Application
11.4.3. Drug Discovery and Development
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Pharmaceutical and Biotechnology Companies
11.5.2. Academic and Research Institutes
11.5.3. Contract Research Organizations (CROs)
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region

12. Asia Pacific Polyclonal Antibody Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type, 2020-2034
12.3.1. Primary Antibodies
12.3.2. Secondary Antibodies
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Diagnostic & Therapeutic Application
12.4.2. Research Application
12.4.3. Drug Discovery and Development
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Pharmaceutical and Biotechnology Companies
12.5.2. Academic and Research Institutes
12.5.3. Contract Research Organizations (CROs)
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region

13. Latin America Polyclonal Antibody Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type, 2020-2034
13.3.1. Primary Antibodies
13.3.2. Secondary Antibodies
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Diagnostic & Therapeutic Application
13.4.2. Research Application
13.4.3. Drug Discovery and Development
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Pharmaceutical and Biotechnology Companies
13.5.2. Academic and Research Institutes
13.5.3. Contract Research Organizations (CROs)
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region

14. Middle East & Africa Polyclonal Antibody Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Type, 2020-2034
14.3.1. Primary Antibodies
14.3.2. Secondary Antibodies
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Diagnostic & Therapeutic Application
14.4.2. Research Application
14.4.3. Drug Discovery and Development
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Pharmaceutical and Biotechnology Companies
14.5.2. Academic and Research Institutes
14.5.3. Contract Research Organizations (CROs)
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region

15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Good Biotech Corp
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Rockland Immunochemicals, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. EpigenTek Group Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Innovagen AB
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. GeneTex, Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Abcam Limited
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. GenScript Biotech
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. The Merck Group
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. IGY Life Sciences
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Thermo Fisher Scientific Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Takara Bio USA, Inc.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. GenWay Biotech, Inc.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview

List of Tables

Table 01: Global Polyclonal Antibody Market Size (US$ Bn) Forecast, by Type, 2020-2034

Table 02: Global Polyclonal Antibody Market Size (US$ Bn) Forecast, by Application, 2020-2034

Table 03: Global Polyclonal Antibody Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 04: Global Polyclonal Antibody Market Size (US$ Bn) Forecast, by Region, 2020-2034

Table 05: North America Polyclonal Antibody Market Size (US$ Bn) Forecast, by Country, 2020-2034

Table 06: North America Polyclonal Antibody Market Size (US$ Bn) Forecast, by Type, 2020-2034

Table 07: North America Polyclonal Antibody Market Size (US$ Bn) Forecast, by Application, 2020-2034

Table 08: North America Polyclonal Antibody Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 09: Europe Polyclonal Antibody Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 10: Europe Polyclonal Antibody Market Size (US$ Bn) Forecast, by Type, 2020-2034

Table 11: Europe Polyclonal Antibody Market Size (US$ Bn) Forecast, by Application, 2020-2034

Table 12: Europe Polyclonal Antibody Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 13: Asia Pacific Polyclonal Antibody Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Asia Pacific Polyclonal Antibody Market Size (US$ Bn) Forecast, by Type, 2020-2034

Table 15: Asia Pacific Polyclonal Antibody Market Size (US$ Bn) Forecast, by Application, 2020-2034

Table 16: Asia Pacific Polyclonal Antibody Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 17: Latin America Polyclonal Antibody Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 18: Latin America Polyclonal Antibody Market Size (US$ Bn) Forecast, by Type, 2020-2034

Table 19: Latin America Polyclonal Antibody Market Size (US$ Bn) Forecast, by Application, 2020-2034

Table 20: Latin America Polyclonal Antibody Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 21: Middle East & Africa Polyclonal Antibody Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Middle East & Africa Polyclonal Antibody Market Size (US$ Bn) Forecast, by Type, 2020-2034

Table 23: Middle East & Africa Polyclonal Antibody Market Size (US$ Bn) Forecast, by Application, 2020-2034

Table 24: Middle East & Africa Polyclonal Antibody Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

Figure 01: Global Polyclonal Antibody Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Global Polyclonal Antibody Market Revenue (US$ Bn), by Type, 2023

Figure 03: Global Polyclonal Antibody Market Value Share, by Type, 2023

Figure 04: Global Polyclonal Antibody Market Revenue (US$ Bn), by Application, 2023

Figure 05: Global Polyclonal Antibody Market Value Share, by Application, 2023

Figure 06: Global Polyclonal Antibody Market Revenue (US$ Bn), by End-user, 2023

Figure 07: Global Polyclonal Antibody Market Value Share, by End-user, 2023

Figure 08: Global Polyclonal Antibody Market Value Share, by Region, 2023

Figure 09: Global Polyclonal Antibody Market Value (US$ Bn) Forecast, 2020-2034

Figure 10: Global Polyclonal Antibody Market Value Share Analysis, by Type, 2023 and 2034

Figure 11: Global Polyclonal Antibody Market Attractiveness Analysis, by Region, 2024-2034

Figure 12: Global Polyclonal Antibody Market Value Share Analysis, by Application, 2023 and 2034

Figure 13: Global Polyclonal Antibody Market Attractiveness Analysis, by Application, 2024-2034

Figure 14: Global Polyclonal Antibody Market Value Share Analysis, by End-user, 2023 and 2034

Figure 15: Global Polyclonal Antibody Market Attractiveness Analysis, by End-user, 2024-2034

Figure 16: Global Polyclonal Antibody Market Value Share Analysis, by Region, 2023 and 2034

Figure 17: Global Polyclonal Antibody Market Attractiveness Analysis, by Region, 2024-2034

Figure 18: North America Polyclonal Antibody Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 19: North America Polyclonal Antibody Market Attractiveness Analysis, by Country, 2024-2034

Figure 20: North America Polyclonal Antibody Market Value Share Analysis, by Country, 2023 and 2034

Figure 21: North America Polyclonal Antibody Market Value Share Analysis, by Type, 2023 and 2034

Figure 22: North America Polyclonal Antibody Market Value Share Analysis, by Application, 2023 and 2034

Figure 23: North America Polyclonal Antibody Market Value Share Analysis, by End-user, 2023 and 2034

Figure 24: North America Polyclonal Antibody Market Attractiveness Analysis, by Region, 2024-2034

Figure 25: North America Polyclonal Antibody Market Attractiveness Analysis, by Application, 2024-2034

Figure 26: North America Polyclonal Antibody Market Attractiveness Analysis, by End-user, 2024-2034

Figure 27: Europe Polyclonal Antibody Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 28: Europe Polyclonal Antibody Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 29: Europe Polyclonal Antibody Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 30: Europe Polyclonal Antibody Market Value Share Analysis, by Type, 2023 and 2034

Figure 31: Europe Polyclonal Antibody Market Value Share Analysis, by Application, 2023 and 2034

Figure 32: Europe Polyclonal Antibody Market Value Share Analysis, by End-user, 2023 and 2034

Figure 33: Europe Polyclonal Antibody Market Attractiveness Analysis, by Region, 2024-2034

Figure 34: Europe Polyclonal Antibody Market Attractiveness Analysis, by Application, 2024-2034

Figure 35: Europe Polyclonal Antibody Market Attractiveness Analysis, by End-user, 2024-2034

Figure 36: Asia Pacific Polyclonal Antibody Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 37: Asia Pacific Polyclonal Antibody Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 38: Asia Pacific Polyclonal Antibody Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 39: Asia Pacific Polyclonal Antibody Market Value Share Analysis, by Type, 2023 and 2034

Figure 40: Asia Pacific Polyclonal Antibody Market Value Share Analysis, by Application, 2023 and 2034

Figure 41: Asia Pacific Polyclonal Antibody Market Value Share Analysis, by End-user, 2023 and 2034

Figure 42: Asia Pacific Polyclonal Antibody Market Attractiveness Analysis, by Region, 2024-2034

Figure 43: Asia Pacific Polyclonal Antibody Market Attractiveness Analysis, by Application, 2024-2034

Figure 44: Asia Pacific Polyclonal Antibody Market Attractiveness Analysis, by End-user, 2024-2034

Figure 45: Latin America Polyclonal Antibody Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 46: Latin America Polyclonal Antibody Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 47: Latin America Polyclonal Antibody Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 48: Latin America Polyclonal Antibody Market Value Share Analysis, by Type, 2023 and 2034

Figure 49: Latin America Polyclonal Antibody Market Value Share Analysis, by Application, 2023 and 2034

Figure 50: Latin America Polyclonal Antibody Market Value Share Analysis, by End-user, 2023 and 2034

Figure 51: Latin America Polyclonal Antibody Market Attractiveness Analysis, by Region, 2024-2034

Figure 52: Latin America Polyclonal Antibody Market Attractiveness Analysis, by Application, 2024-2034

Figure 53: Latin America Polyclonal Antibody Market Attractiveness Analysis, by End-user, 2024-2034

Figure 54: Middle East & Africa Polyclonal Antibody Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 55: Middle East & Africa Polyclonal Antibody Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 56: Middle East & Africa Polyclonal Antibody Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 57: Middle East & Africa Polyclonal Antibody Market Value Share Analysis, by Type, 2023 and 2034

Figure 58: Middle East & Africa Polyclonal Antibody Market Value Share Analysis, by Application, 2023 and 2034

Figure 59: Middle East & Africa Polyclonal Antibody Market Value Share Analysis, by End-user, 2023 and 2034

Figure 60: Middle East & Africa Polyclonal Antibody Market Attractiveness Analysis, by Region, 2024-2034

Figure 61: Middle East & Africa Polyclonal Antibody Market Attractiveness Analysis, by Application, 2024-2034

Figure 62: Middle East & Africa Polyclonal Antibody Market Attractiveness Analysis, by End-user, 2024-2034

△ 一番上に戻る